Literature DB >> 31874856

The Deubiquitinase USP38 Promotes NHEJ Repair through Regulation of HDAC1 Activity and Regulates Cancer Cell Response to Genotoxic Insults.

Yongfeng Yang1,2, Chuanzhen Yang1,2, Tingting Li3, Shuyu Yu1,2, Tingting Gan4, Jiazhi Hu4, Jun Cui5,6, Xiaofeng Zheng7,2.   

Abstract

The DNA damage response (DDR) is essential for maintaining genome integrity. Mounting evidence reveals that protein modifications play vital roles in the DDR. Here, we show that USP38 is involved in the DDR by regulating the activity of HDAC1. In response to DNA damage, USP38 interacted with HDAC1 and specifically removed the K63-linked ubiquitin chain promoting the deacetylase activity of HDAC1. As a result, HDAC1 was able to deacetylate H3K56. USP38 deletion resulted in persistent focal accumulation of nonhomologous end joining (NHEJ) factors at DNA damage sites and impaired NHEJ efficiency, causing genome instability and sensitizing cancer cells to genotoxic insults. Knockout of USP38 rendered mice hypersensitive to irradiation and shortened survival. In addition, USP38 was expressed at low levels in certain types of cancers including renal cell carcinoma, indicating dysregulation of USP38 expression contributes to genomic instability and may lead to tumorigenesis. In summary, this study identifies a critical role of USP38 in modulating genome integrity and cancer cell resistance to genotoxic insults by deubiquitinating HDAC1 and regulating its deacetylation activity. SIGNIFICANCE: This study demonstrates that USP38 regulates genome stability and mediates cancer cell resistance to DNA-damaging therapy, providing insight into tumorigenesis and implicating USP38 as a potential target for cancer diagnosis. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31874856     DOI: 10.1158/0008-5472.CAN-19-2149

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Deubiquitinase OTUD6A promotes breast cancer progression by increasing TopBP1 stability and rendering tumor cells resistant to DNA-damaging therapy.

Authors:  Yan Zhao; Xinping Huang; Dan Zhu; Min Wei; Jiechen Luo; Shuyu Yu; Yonglu Tian; Xiaofeng Zheng
Journal:  Cell Death Differ       Date:  2022-06-29       Impact factor: 15.828

Review 2.  DNA Double-Strand Breaks as Pathogenic Lesions in Neurological Disorders.

Authors:  Vincent E Provasek; Joy Mitra; Vikas H Malojirao; Muralidhar L Hegde
Journal:  Int J Mol Sci       Date:  2022-04-22       Impact factor: 6.208

3.  Mitochondrial dysfunction induces radioresistance in colorectal cancer by activating [Ca2+]m-PDP1-PDH-histone acetylation retrograde signaling.

Authors:  Yingying Shi; You Wang; Huangang Jiang; Xuehua Sun; Hui Xu; Xue Wei; Yan Wei; Guohui Xiao; Zhiyin Song; Fuxiang Zhou
Journal:  Cell Death Dis       Date:  2021-09-06       Impact factor: 8.469

Review 4.  Emerging Roles of Non-proteolytic Ubiquitination in Tumorigenesis.

Authors:  Xiu Yin; Qingbin Liu; Fen Liu; Xinchen Tian; Tinghao Yan; Jie Han; Shulong Jiang
Journal:  Front Cell Dev Biol       Date:  2022-07-06

Review 5.  Role of K63-linked ubiquitination in cancer.

Authors:  Liangzi Cao; Xiaofang Liu; Bowen Zheng; Chengzhong Xing; Jingwei Liu
Journal:  Cell Death Discov       Date:  2022-10-06

6.  USP38 Inhibits Zika Virus Infection by Removing Envelope Protein Ubiquitination.

Authors:  Yingchong Wang; Qin Li; Dingwen Hu; Daolong Gao; Wenbiao Wang; Kailang Wu; Jianguo Wu
Journal:  Viruses       Date:  2021-10-08       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.